As of the latest Form 4 filed Dec 12, 2025.
What Aardvark Therapeutics, Inc. Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 11 most recent filings for AARD.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 2025-12-11 | Sun Nelson Chief Financial Officer | PPurchase | +3.00K | $14.40 | $43.2K | No | Form 4 ↗ |
| 2025-12-12 | 2025-12-11 | Lee Tien-Li Chief Executive Officer | PPurchase | +7.00K | $14.49 | $101K | No | Form 4 ↗ |
| 2025-10-16 | 2025-10-15 | Lee Tien-Li Chief Executive Officer | MExercise | +1.23K | $4.24 | $5.21K | No | Form 4 ↗ |
| 2025-10-16 | 2025-10-15 | Jones Bryan Chief Operating Officer | MExercise | +1.25K | $4.24 | $5.30K | No | Form 4 ↗ |
| 2025-09-16 | 2025-09-15 | Lee Tien-Li Chief Executive Officer | PPurchase | +3.50K | $9.94 | $34.8K | No | Form 4 ↗ |
| 2025-09-16 | 2025-09-15 | Lee Tien-Li, Chief Executive Officer | PPurchase | +6.50K | $9.51 | $61.8K | No | Form 4 ↗ |
| 2025-09-12 | 2025-09-12 | Lee Tien-Li Chief Executive Officer | PPurchase | +5.00K | $8.50 | $42.5K | No | Form 4 ↗ |
| 2025-09-12 | 2025-09-11 | Lee Tien-Li, Chief Executive Officer | PPurchase | +6.00K | $7.82 | $46.9K | No | Form 4 ↗ |
| 2025-09-12 | 2025-09-10 | Lee Tien-Li, Chief Executive Officer | PPurchase | +9.00K | $7.91 | $71.2K | No | Form 4 ↗ |
| 2025-09-10 | 2025-09-09 | Sun Nelson Chief Financial Officer | PPurchase | +6.00K | $8.07 | $48.4K | No | Form 4 ↗ |
| 2025-08-29 | 2025-08-28 | Lee Tien-Li Chief Executive Officer | MExercise | +17.2K | $4.24 | $73.0K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AARD’s full analysis or the market-wide insider trading feed. The tabs above jump to AARD’s other SEC data.
Source: SEC Form 4 filings for AARD, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.